Nicholas B. Hawkins Sells 5,000 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) CFO Nicholas B. Hawkins sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $7.35, for a total transaction of $36,750.00. Following the completion of the transaction, the chief financial officer now owns 219,659 shares in the company, valued at approximately $1,614,493.65. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Arteris Price Performance

Shares of NASDAQ AIP opened at $7.10 on Friday. Arteris, Inc. has a 12-month low of $4.20 and a 12-month high of $9.54. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.17. The firm’s 50-day moving average price is $7.52 and its 200-day moving average price is $7.63. The stock has a market capitalization of $273.20 million, a price-to-earnings ratio of -6.89 and a beta of 1.11.

Arteris (NASDAQ:AIP) last released its quarterly earnings results on Thursday, August 1st. The company reported ($0.21) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.07). Arteris had a negative return on equity of 274.66% and a negative net margin of 68.37%. The firm had revenue of $14.58 million for the quarter, compared to analysts’ expectations of $13.68 million. During the same period in the prior year, the firm posted ($0.25) earnings per share. On average, equities research analysts anticipate that Arteris, Inc. will post -0.9 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AIP has been the topic of several recent analyst reports. Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 price objective on shares of Arteris in a research report on Monday, August 5th. Westpark Capital reiterated a “buy” rating and set a $11.00 target price on shares of Arteris in a research report on Wednesday, July 31st.

Institutional Trading of Arteris

Large investors have recently made changes to their positions in the stock. The Manufacturers Life Insurance Company purchased a new stake in Arteris in the second quarter worth about $86,000. Algert Global LLC purchased a new stake in shares of Arteris during the 2nd quarter valued at $115,000. Rhumbline Advisers boosted its holdings in Arteris by 2,182.8% in the second quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock worth $239,000 after acquiring an additional 30,428 shares in the last quarter. CloudAlpha Capital Management Limited Hong Kong acquired a new stake in Arteris in the 2nd quarter worth approximately $554,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Arteris during the second quarter valued at $580,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.